Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

IND SWIFT LA Gains 14%; BSE HEALTHCARE Index Up 0.6%
Wed, 26 Aug 12:50

IND SWIFT LA Gains 14%; BSE HEALTHCARE Index Up 0.6%Image source: ipopba/www.istockphoto.com

IND SWIFT LA share price has zoomed 14% and is presently trading at Rs 368.7.

Meanwhile, the BSE HEALTHCARE index is at 51,192.8 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are COHANCE LIFESCIENCES (up 3.7%) and Divis Laboratories (up 3.5%).

J.B.Chemicals (down 3.7%) and GRANULES INDIA (down 2.6%) are among the top losers today.

Over the last one year, IND SWIFT LA has moved up from Rs 96.7 to Rs 368.7, registering a gain of Rs 272.0 (up 281.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 44,815.9 to 51,192.8, registering a gain of 14.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 115.9%), GRANULES INDIA (up 78.6%) and Aurobindo Pharma (up 52.1%).

Discover: Where the opportunities are emerging for the next 3-5 years

What About the Benchmark Indices?

The BSE Sensex is at 77,685.2 .

The top gainers among the BSE Sensex today are Kotak Bank (up 3.4%) and Axis Bank (up 1.4%). The most traded stocks in the BSE Sensex are Kotak Bank and HDFC Bank.

In the meantime, NSE Nifty is at 24,283.9 (down 0.2%). Tech Mahindra and Shriram Transport are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved down from 81,635.9 to 77,685.2, registering a loss of 3,950.7 points (down 4.8%).

IND SWIFT LA Financial Update...

IND SWIFT LA net profit grew 184.1% YoY to Rs 246 million for the quarter ended June 2026, compared to a profit of Rs 86 million a year ago. Net sales rose 20.9% to Rs 1,915 million during the period as against Rs 1,583 million in April-June 2025.

For the year ended March 2025, IND SWIFT LA reported 40.6% decrease in net profit to Rs 2,505 million compared to net profit of Rs 4,215 million during FY24. Revenue of the company fell 56.1% to Rs 5,617 million during FY25.

The current Price to earnings ratio of IND SWIFT LA, based on rolling 12 month earnings, stands at 56.0.


Equitymaster requests your view! Post a comment on "IND SWIFT LA Gains 14%; BSE HEALTHCARE Index Up 0.6%". Click here!